Markel Group (MKL) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
11 Apr, 2026Executive summary
All reportable segments contributed positively in 2025, with significant progress from decisive long-term actions, including exiting underperforming businesses and leadership changes.
Operating income reached $3.2 billion for 2025, with adjusted operating income at $2.3 billion, reflecting broad-based contributions from all segments.
Markel Insurance delivered strong results, with a 92.9% combined ratio in Q4 and $1.4 billion in adjusted operating income for the year, up from $1.2 billion in 2024.
Markel Insurance underwent simplification and refocusing, with improved underwriting profitability and higher net investment income.
Financial highlights
Consolidated operating revenues rose 8% for the quarter and 5% for the year; adjusted operating income increased 19% for the quarter and 10% for the year.
Operating revenues grew to $15.5 billion, and comprehensive income to shareholders was $2.6 billion.
Net investment gains were $212 million in Q4 and $1.1 billion for the year, down from $1.8 billion in 2024.
Net investment income grew 5% to $970 million, driven by higher yields and increased fixed maturity holdings.
Operating cash flow reached $2.8 billion, up from $2.6 billion in 2024; share repurchases reached $429.5 million, reducing shares outstanding to 12.6 million.
Outlook and guidance
Leadership expects continued improvement in combined ratio and return on equity, with a focus on simplification, technology investment, and operational efficiency.
Anticipates a $2 billion decrease in underwriting gross written premiums in 2026 due to the exit from Global Reinsurance and changes in the Hagerty partnership, but expects long-term benefits to profitability.
Management emphasizes long-term performance, with a five-year compound annual growth rate in intrinsic value per share of 15%.
Market conditions in specialty insurance are softening, with increased competition and pricing pressure, but the company remains confident in its diversified portfolio and disciplined underwriting.
The company is positioned to continue compounding shareholder value across generations.
Latest events from Markel Group
- Board backs charter amendment, opposes climate and special meeting proposals, and details pay.MKL
Proxy filing2 Apr 2026 - Key votes include director elections, auditor ratification, and proposals on ESG and shareholder rights.MKL
Proxy filing2 Apr 2026 - Board recommends all management proposals and opposes both shareholder proposals at the 2026 meeting.MKL
Proxy Filing6 Mar 2026 - H1 2024 revenues up 5%, but Q2 income fell on equity volatility and discontinued product losses.MKL
Q2 20242 Feb 2026 - Net income and operating income surged, with robust investment gains and ongoing share repurchases.MKL
Q3 202417 Jan 2026 - Operating income jumped 27% to $3.71B, with improved insurance and major share repurchases.MKL
Q4 20248 Jan 2026 - Key votes include director elections, auditor ratification, and ESG-related shareholder proposals.MKL
Proxy Filing1 Dec 2025 - Board recommends director slate, performance-based pay, and opposes GHG and voting proposals.MKL
Proxy Filing1 Dec 2025 - Q1 2025 saw lower profits from investment losses, but insurance and capital positions improved.MKL
Q1 202529 Nov 2025